Clinical Trial Update: SB-681323-Methotrexate Interaction Study [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating the interaction between SB-681323 and methotrexate in rheumatoid arthritis has completed. The study was sponsored by GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• SB-681323

Snippet

Sponsor: GlaxoSmithKline | Conditions: Arthritis, Rheumatoid | Phase 1 | Status: COMPLETED